While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

SINGAPORE’S authorities are reviewing advertisements that telemedicine providers have put up for certain weight-loss drugs, ...

Altimmune (ALT) has received a new Buy rating, initiated by UBS analyst, Eliana Merle. Eliana Merle has given her Buy rating due to a ...

In DIO Mice, we saw a synergistic effect with GLP-1s due to 7's unique mechanism of action. When administered as an add on ..

As diabetes cases surge across Europe, healthcare systems are grappling with an escalation, leaving millions without ...

Cash, cash equivalents and marketable securities of $372.8 million, including $172.7 million equity raise in September, expected to provide runway into 2028 ...

Cloudflare’s (NYSE: NET) biggest problem in 2024 is its stock price valuation. Trading well over 100X earnings, the market is ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...